A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 3,786 shares of BSX stock, worth $340,209. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,786
Previous 2,859 32.42%
Holding current value
$340,209
Previous $220,000 44.09%
% of portfolio
0.1%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$72.96 - $84.0 $67,633 - $77,868
927 Added 32.42%
3,786 $317,000
Q2 2024

Jul 05, 2024

BUY
$67.33 - $77.71 $192,496 - $222,172
2,859 New
2,859 $220,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Thurston, Springer, Miller, Herd & Titak, Inc. Portfolio

Follow Thurston, Springer, Miller, Herd & Titak, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thurston, Springer, Miller, Herd & Titak, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thurston, Springer, Miller, Herd & Titak, Inc. with notifications on news.